{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Berberine", "experimental autoimmune encephalomyelitis", "multiple sclerosis", "myelin oligodendrocyte glycoprotein"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36705421", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["e766", "10.1002/iid3.766"], "Journal": {"ISSN": "2050-4527", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jan"}}, "Title": "Immunity, inflammation and disease", "ISOAbbreviation": "Immun Inflamm Dis"}, "ArticleTitle": "Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells.", "Pagination": {"StartPage": "e766", "MedlinePgn": "e766"}, "Abstract": {"AbstractText": ["Among the most frequent demyelinating autoimmune disorders of the central nervous system (CNS) is multiple sclerosis. Experimental autoimmune encephalomyelitis (EAE) is used as an animal model of multiple sclerosis. Berberine is an alkaloid found in some medicinal plants with anti-inflammatory effects.", "C57BL/6 female mice were used and divided into three groups: (1) The control group received PBS, (2) the low-dose treatment group received 10\u2009mg/kg of berberine, and (3) The high-dose treatment group received 30\u2009mg/kg of berberine. Myelin Oligodendrocyte Glycoprotein and complete Freund's adjuvant were subcutaneously administered to induce EAE. Mice were given intraperitoneal injections of pertussis toxin on the day of immunization and 2\u2009days later. Histological studies showed low lymphocyte infiltration and demyelination of CNS in the treated groups.", "The clinical scores of the treatment group with low-dose berberine (T1: 2\u2009\u00b1\u20090.13) and high-dose berberine (T2: 1.5\u2009\u00b1\u20090.14) were significantly (p\u2009<\u2009.001) lower than the control group (CTRL: 4.5\u2009\u00b1\u20090.13). Treatment groups decreased pro-inflammatory cytokines (IFN-\u03b3, TNF-\u03b1, interleukin [IL]-17) (p\u2009<\u2009.001) as well as increased anti-inflammatory cytokine expression (IL-4, IL-10, IL-27, IL-33, IL-35, TGF-\u03b2) (p\u2009<\u2009.01) when compared to the CTRL group. Treatment groups with berberine reduced expression of the Th1 and Th17 cytokines and transcription factors (p\u2009<\u2009.001) and increased expression of transcription factors and Th2 and Treg cytokines (p\u2009<\u2009.01) in contrast to CTRL group.", "Berberine appears to have a protective effect on disease development and alleviating disease status in EAE, which appears to be due to the cell expansion and function of Treg and Th2 cells in addition to berberine's anti-inflammatory properties."], "CopyrightInformation": "\u00a9 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Tavaf", "ForeName": "Maryam J", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Soltanmohammadi", "ForeName": "Azita", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Zargarani", "ForeName": "Simin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology and Allergy, Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Yazdanpanah", "ForeName": "Esmaeil", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Sadighimoghaddam", "ForeName": "Bizhan", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Yousefi", "ForeName": "Bahman", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nervous System Stem Cells Research Center and Department of Tissue Engineering and Applied Cellular Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Sameni", "ForeName": "Hamid R", "Initials": "HR"}, {"Identifier": ["0000-0002-9876-4943"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}, {"Identifier": [], "Affiliation": "Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Haghmorad", "ForeName": "Dariush", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Immun Inflamm Dis", "NlmUniqueID": "101635460", "ISSNLinking": "2050-4527"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Berberine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Encephalomyelitis, Autoimmune, Experimental"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Multiple Sclerosis"}, {"QualifierName": [], "DescriptorName": "Neuroinflammatory Diseases"}, {"QualifierName": [], "DescriptorName": "T-Lymphocytes, Regulatory"}, {"QualifierName": [], "DescriptorName": "Th2 Cells"}, {"QualifierName": [], "DescriptorName": "Transcription Factors"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kamma E, Lasisi W, Libner C, Ng HS, Plemel JR. Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics. J Neuroinflam. 2022;19(1):45. 10.1186/s12974-022-02408-y", "ArticleIdList": ["10.1186/s12974-022-02408-y", "PMC8830034", "35144628"]}, {"Citation": "Yadav SK, Mindur JE, Ito K, Dhib\u2010Jalbut S. Advances in the immunopathogenesis of multiple sclerosis. Curr Opin Neurol. 2015;28(3):206\u2010219. 10.1097/wco.0000000000000205", "ArticleIdList": ["10.1097/wco.0000000000000205", "25887768"]}, {"Citation": "H\u00f8glund RA. Multiple sclerosis and the role of immune cells. World J Exp Med. 2014;4(3):27\u201037. 10.5493/wjem.v4.i3.27", "ArticleIdList": ["10.5493/wjem.v4.i3.27", "PMC4172701", "25254187"]}, {"Citation": "Psenicka MW, Smith BC, Tinkey RA, Williams JL. Connecting neuroinflammation and neurodegeneration in multiple sclerosis: are oligodendrocyte precursor cells a nexus of disease? Front Cell Neurosci. 2021;15:654284. 10.3389/fncel.2021.654284", "ArticleIdList": ["10.3389/fncel.2021.654284", "PMC8255483", "34234647"]}, {"Citation": "Titus HE, Chen Y, Podojil JR, et al. Pre\u2010clinical and clinical implications of \u201cInside\u2010Out\u201d vs. \u201cOutside\u2010In\u201d paradigms in multiple sclerosis etiopathogenesis. Front Cell Neurosci. 2020;14:599717. 10.3389/fncel.2020.599717", "ArticleIdList": ["10.3389/fncel.2020.599717", "PMC7654287", "33192332"]}, {"Citation": "Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, Pirko I. The relevance of animal models in multiple sclerosis research. Pathophysiology. 2011;18(1):21\u201029. 10.1016/j.pathophys.2010.04.004", "ArticleIdList": ["10.1016/j.pathophys.2010.04.004", "PMC3858209", "20537877"]}, {"Citation": "Li C, Xi Y, Li S, et al. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation. Mol Immunol. 2015;67(2 Pt B):444\u2010454. 10.1016/j.molimm.2015.07.013", "ArticleIdList": ["10.1016/j.molimm.2015.07.013", "26224047"]}, {"Citation": "Matejuk A, Vandenbark AA, Offner H. Cross\u2010talk of the CNS with immune cells and functions in health and disease. Front Neurol. 2021;12:672455. 10.3389/fneur.2021.672455", "ArticleIdList": ["10.3389/fneur.2021.672455", "PMC8200536", "34135852"]}, {"Citation": "Benallegue N, Kebir H, Alvarez JI. Neuroinflammation: extinguishing a blaze of T cells. Immunol Rev. 2022;311:151\u2010176. 10.1111/imr.13122", "ArticleIdList": ["10.1111/imr.13122", "PMC9489683", "35909230"]}, {"Citation": "Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KHG. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1\u201011. 10.1111/j.1365-2249.2010.04143.x", "ArticleIdList": ["10.1111/j.1365-2249.2010.04143.x", "PMC2990924", "20682002"]}, {"Citation": "Kourko O, Seaver K, Odoardi N, Basta S, Gee K. IL\u201027, IL\u201030, and IL\u201035: a cytokine triumvirate in cancer. Front Oncol. 2019;9:969. 10.3389/fonc.2019.00969", "ArticleIdList": ["10.3389/fonc.2019.00969", "PMC6797860", "31681561"]}, {"Citation": "Hirahara K, Ghoreschi K, Yang X\u2010P, et al. Interleukin\u201027 priming of T cells controls IL\u201017 production in trans via induction of the ligand PD\u2010L1. Immunity. 2012;36(6):1017\u20101030. 10.1016/j.immuni.2012.03.024", "ArticleIdList": ["10.1016/j.immuni.2012.03.024", "PMC3785111", "22726954"]}, {"Citation": "Legroux L, Arbour N. Multiple sclerosis and T lymphocytes: an entangled story. J Neuroimmune Pharmacol. 2015;10(4):528\u2010546. 10.1007/s11481-015-9614-0", "ArticleIdList": ["10.1007/s11481-015-9614-0", "PMC5052065", "25946987"]}, {"Citation": "Rao X, Hua F, Zhang L, et al. Dual roles of interleukin\u201033 in cognitive function by regulating central nervous system inflammation. J Transl Med. 2022;20(1):369. 10.1186/s12967-022-03570-w", "ArticleIdList": ["10.1186/s12967-022-03570-w", "PMC9382782", "35974336"]}, {"Citation": "Collison LW, Chaturvedi V, Henderson AL, et al. IL\u201035\u2010mediated induction of a potent regulatory T cell population. Nature Immunol. 2010;11(12):1093\u20101101. 10.1038/ni.1952", "ArticleIdList": ["10.1038/ni.1952", "PMC3008395", "20953201"]}, {"Citation": "Jiang Y, Wu A, Zhu C, et al. The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase\u20109 and laminin degradation in experimental autoimmune encephalomyelitis. Neurol Res. 2013;35(4):360\u2010368. 10.1179/1743132812y.0000000156", "ArticleIdList": ["10.1179/1743132812y.0000000156", "23540404"]}, {"Citation": "Zhang M, Feng L, Li J, Chen L. Therapeutic potential and mechanisms of berberine in cardiovascular disease. Current Pharmacology Reports. 2016;2(6):281\u2010292. 10.1007/s40495-016-0070-1", "ArticleIdList": ["10.1007/s40495-016-0070-1"]}, {"Citation": "Wang X, Jiang S, Sun Q. Effects of berberine on human rheumatoid arthritis fibroblast\u2010like synoviocytes. Exp Biol Med. 2011;236(7):859\u2010866. 10.1258/ebm.2011.010366", "ArticleIdList": ["10.1258/ebm.2011.010366", "21676922"]}, {"Citation": "Habtemariam S. Berberine and inflammatory bowel disease: a concise review. Pharmacol Res. 2016;113(Pt A):592\u2010599. 10.1016/j.phrs.2016.09.041", "ArticleIdList": ["10.1016/j.phrs.2016.09.041", "27697643"]}, {"Citation": "Behl T, Singh S, Sharma N, et al. Expatiating the pharmacological and nanotechnological aspects of the alkaloidal drug berberine: current and future trends. Molecules. 2022;27(12):3705. 10.3390/molecules27123705", "ArticleIdList": ["10.3390/molecules27123705", "PMC9229453", "35744831"]}, {"Citation": "Och A, Podg\u00f3rski R, Nowak R. Biological activity of Berberine\u2010A summary update. Toxins. 2020;12(11):713. 10.3390/toxins12110713", "ArticleIdList": ["10.3390/toxins12110713", "PMC7697704", "33198257"]}, {"Citation": "Yan F, Wang L, Shi Y, et al. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS\u2010treated mice. Am J Physiol Gastrointest Liver Physiol. 2012;302(5):G504\u2010G514. 10.1152/ajpgi.00312.2011", "ArticleIdList": ["10.1152/ajpgi.00312.2011", "PMC3311435", "22173918"]}, {"Citation": "Ma X, Jiang Y, Wu A, et al. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One. 2010;5(10):e13489. 10.1371/journal.pone.0013489", "ArticleIdList": ["10.1371/journal.pone.0013489", "PMC2957444", "20976070"]}, {"Citation": "Chandirasegaran G, Elanchezhiyan C, Ghosh K, Sethupathy S. Berberine chloride ameliorates oxidative stress, inflammation and apoptosis in the pancreas of Streptozotocin induced diabetic rats. Biomed Pharmacother Biomed Pharmacother. 2017;95:175\u2010185. 10.1016/j.biopha.2017.08.040", "ArticleIdList": ["10.1016/j.biopha.2017.08.040", "28843149"]}, {"Citation": "Mahmoudi MB, Mahmoudi M, Rab SZT, et al. Calcium intervention ameliorates experimental model of multiple sclerosis. Oman Med J. 2014;29(3):185\u2010189. 10.5001/omj.2014.46", "ArticleIdList": ["10.5001/omj.2014.46", "PMC4052390", "24936267"]}, {"Citation": "Haghmorad D, Yazdanpanah E, Sadighimoghaddam B, et al. Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells. Acta Neurol Belg. 2021;121(6):1685\u20101692. 10.1007/s13760-020-01475-3", "ArticleIdList": ["10.1007/s13760-020-01475-3", "32812134"]}, {"Citation": "Haghmorad D, Yazdanpanah E, Jadid Tavaf M, et al. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25\u2010dihydroxyvitamin D3. Neurol Res. 2019;41:943\u2010957. 10.1080/01616412.2019.1650218", "ArticleIdList": ["10.1080/01616412.2019.1650218", "31402771"]}, {"Citation": "Luo J, Chen R, Zeng S, et al. The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway. Biochem Biophys Res Commun. 2017;490(3):927\u2010932.", "ArticleIdList": ["28655617"]}, {"Citation": "Constantinescu CS, Farooqi N, O'Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS): EAE as model for MS. Br J Pharmacol. 2011;164(4):1079\u20101106.", "ArticleIdList": ["PMC3229753", "21371012"]}, {"Citation": "Wang J, Niu X, Wu C, Wu D. Naringenin modifies the development of lineage\u2010specific effector CD4+ T cells. Front Immunol. 2018;9:2267.", "ArticleIdList": ["PMC6174281", "30327657"]}, {"Citation": "Trenova A, Slavov G. Cytokines in multiple sclerosis\u2013possible targets for immune therapies. J Neurol Exp Neurosci. 2016;1(2):25\u201029."}, {"Citation": "Qin X, Guo BT, Wan B, et al. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine. J Immunol. 2010;185(3):1855\u20101863.", "ArticleIdList": ["20622114"]}, {"Citation": "Ehteshamfar SM, Akhbari M, Afshari JT, et al. Anti\u2010inflammatory and immune\u2010modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation. J Cell Mol Med. 2020;24(23):13573\u201013588. 10.1111/jcmm.16049", "ArticleIdList": ["10.1111/jcmm.16049", "PMC7754052", "33135395"]}, {"Citation": "Loos J, Schmaul S, Noll TM, et al. Functional characteristics of Th1, Th17, and ex\u2010Th17 cells in EAE revealed by intravital two\u2010photon microscopy. J Neuroinflammation. 2020;17(1):357. 10.1186/s12974-020-02021-x", "ArticleIdList": ["10.1186/s12974-020-02021-x", "PMC7694901", "33243290"]}, {"Citation": "Wagner CA, Roqu\u00e9 PJ, Goverman JM. Pathogenic T cell cytokines in multiple sclerosis. J Exp Med. 2020;217(1):e20190460. 10.1084/jem.20190460", "ArticleIdList": ["10.1084/jem.20190460", "PMC7037255", "31611252"]}, {"Citation": "Ghorbani MM, Farazmandfar T, Abediankenari S, Hassannia H, Maleki Z, Shahbazi M. Treatment of EAE mice with Treg, G\u2010MDSC and IL\u20102: a new insight into cell therapy for multiple sclerosis. Immunotherapy. 2022;14(10):789\u2010798. 10.2217/imt-2021-0045", "ArticleIdList": ["10.2217/imt-2021-0045", "35678041"]}, {"Citation": "Kleinewietfeld M, Hafler DA. Regulatory T cells in autoimmune neuroinflammation. Immunol Rev. 2014;259(1):231\u2010244. 10.1111/imr.12169", "ArticleIdList": ["10.1111/imr.12169", "PMC3990868", "24712469"]}, {"Citation": "Wang C, Collins M, Kuchroo VK. Effector T cell differentiation: are master regulators of effector T cells still the masters? Curr Opin Immunol. 2015;37:6\u201010. 10.1016/j.coi.2015.08.001", "ArticleIdList": ["10.1016/j.coi.2015.08.001", "26319196"]}, {"Citation": "Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531\u2010564. 10.1146/annurev.immunol.25.022106.141623", "ArticleIdList": ["10.1146/annurev.immunol.25.022106.141623", "PMC6066374", "22224781"]}, {"Citation": "Fasching P, Stradner M, Graninger W, Dejaco C, Fessler J. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules. 2017;22(1):134. 10.3390/molecules22010134", "ArticleIdList": ["10.3390/molecules22010134", "PMC6155880", "28098832"]}, {"Citation": "Goswami TK, Singh M, Dhawan M, et al. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders\u2014advances and challenges. Hum Vaccines Immunother. 2022;18(1):2035117. 10.1080/21645515.2022.2035117", "ArticleIdList": ["10.1080/21645515.2022.2035117", "PMC9009914", "35240914"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "20"}, {"Year": "2022", "Month": "8", "Day": "3"}, {"Year": "2023", "Month": "1", "Day": "1"}, {"Year": "2023", "Month": "1", "Day": "27", "Hour": "8", "Minute": "23"}, {"Year": "2023", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36705421", "PMC9837936", "10.1002/iid3.766"]}}], "PubmedBookArticle": []}